Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported data

BAKHRIANSYAH, MOHAMMAD

dc.contributor.author	BAKHRIANSYAH, MOHAMMAD
dc.date.accessioned	2020-09-09T02:25:17Z
dc.date.available	2020-09-09T02:25:17Z
dc.date.issued	2019-03-11
dc.identifier.uri	https://repo-dosen.ulm.ac.id//handle/123456789/17785
dc.description.abstract	Important risk factors and over‐the‐counter (OTC) dis‐ pensing of non‐steroidal anti‐inflammatory drugs (NSAIDs) are often not routinely re‐ corded in electronic health records. This study aimed to assess the impact of patient's reports on these factors on the risk of acute myocardial infarction (AMI) for NSAID use acute myocardial infarction, conventional NSAIDs, patient’s reports, pharmacoepidemiology, pharmacy records, selective COX‐2 inhibitors, Utrecht cardiovascular pharmacogenetics study	en_US
dc.publisher	Journal of clinical pharmacy and Therapeutics	en_US
dc.subject	Research Subject Categories::MEDICINE	en_US
dc.title	Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported data	en_US
dc.type	Article	en_US